A total of 40 samples were collected from 14 cities in mid-April under the supervision of the World Health Organization and analyzed at the National Health Institute, said Dr. Rana Safdar, the head of the National Emergency Operation Center. WHO officials could not immediately be reached for comment.
Last year 22 percent of environmental samples tested positive, and 9 percent tested positive in the first quarter of 2016.
Past immunization campaigns have been met with resistance by Islamic extremists, who have spread conspiracy theories that the vaccines are part of a plot to sterilize children or gather intelligence for Western nations. Islamic militants have attacked vaccination centers and health workers taking part in the campaigns.
But Safdar said outreach programs supported by religious scholars have helped to combat the propaganda, bringing the refusal rate down from 1.5 percent to 0.05 percent over the last two years.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
